Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ping Yang

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|September 21, 2012
[Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine]Xiao-Cong Zuo, Hong Yuan, Bi-Kui Zhang, et al.
Pakistan Journal of Pharmaceutical Sciences|April 30, 2013
Effect of pitavastatin in different SLCO1B1 backgrounds on repaglinide pharmacokinetics and pharmacodynamics in healthy Chinese malesJie Zhu, Min Song, Hong-Yi Tan, et al.
Plos One|February 19, 2015
A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium riskYing Li, Xiao-hui Li, Zhi-jun Huang, et al.
Expert Opinion on Investigational Drugs|May 6, 2025
A phase 1, randomized, double-blind, placebo-controlled trial investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of KN056 (a recombinant human GLP-1 variant Fc fusion protein) in healthy Chinese participantsYuan-Fang Qin, Wen-Hua Zhang, Hao-Nan Zhang, et al.
Cancer Chemotherapy and Pharmacology|January 8, 2020
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjectsYa-Nan Liu, Jie Huang, Can Guo, et al.
Pulmonary Circulation|September 25, 2015
HIV protease inhibitors in pulmonary hypertension: rationale and design of a pilot trial in idiopathic pulmonary arterial hypertensionYing Li, Xiao-Hui Li, Zai-Xin Yu, et al.
Neurology and Therapy|February 7, 2022
Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy VolunteersHui Wang, Jie Huang, Shuang Yang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 15, 2013
Effect of amlodipine on the pharmacokinetics of tacrolimus in ratsYa-nan Zhou, Bi-kui Zhang, Jing Li, et al.
Frontiers in Pharmacology|June 7, 2022
Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose StudyYun Kuang, Sai-Ying Wang, Meng-Na Wang, et al.
British Journal of Clinical Pharmacology|April 26, 2020
Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarboseJie Huang, Wen-Yu Liu, Jing-Jing Yu, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|September 21, 2012
[Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine]Xiao-Cong Zuo, Hong Yuan, Bi-Kui Zhang, et al.
Pakistan Journal of Pharmaceutical Sciences|April 30, 2013
Effect of pitavastatin in different SLCO1B1 backgrounds on repaglinide pharmacokinetics and pharmacodynamics in healthy Chinese malesJie Zhu, Min Song, Hong-Yi Tan, et al.
Plos One|February 19, 2015
A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium riskYing Li, Xiao-hui Li, Zhi-jun Huang, et al.
Expert Opinion on Investigational Drugs|May 6, 2025
A phase 1, randomized, double-blind, placebo-controlled trial investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of KN056 (a recombinant human GLP-1 variant Fc fusion protein) in healthy Chinese participantsYuan-Fang Qin, Wen-Hua Zhang, Hao-Nan Zhang, et al.
Cancer Chemotherapy and Pharmacology|January 8, 2020
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjectsYa-Nan Liu, Jie Huang, Can Guo, et al.
Pulmonary Circulation|September 25, 2015
HIV protease inhibitors in pulmonary hypertension: rationale and design of a pilot trial in idiopathic pulmonary arterial hypertensionYing Li, Xiao-Hui Li, Zai-Xin Yu, et al.
Neurology and Therapy|February 7, 2022
Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy VolunteersHui Wang, Jie Huang, Shuang Yang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 15, 2013
Effect of amlodipine on the pharmacokinetics of tacrolimus in ratsYa-nan Zhou, Bi-kui Zhang, Jing Li, et al.
Frontiers in Pharmacology|June 7, 2022
Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose StudyYun Kuang, Sai-Ying Wang, Meng-Na Wang, et al.
British Journal of Clinical Pharmacology|April 26, 2020
Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarboseJie Huang, Wen-Yu Liu, Jing-Jing Yu, et al.
Pageof 14